Dr. Lal PathLabs Limited provides diagnostic and related healthcare tests and services in India and internationally. It operates laboratories for carrying the pathological investigations of various branches of bio-chemistry, hematology, histopathology, microbiology, electrophoresis, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigations. The company also offers lab staff training; technical; and lab management services. As of March 31, 2022, the company had 277 clinical laboratories, including National Reference Lab at Delhi and Regional Reference Lab at Kolkata; and 4,731 patient service centers and 10,599 pick-up points. Dr. Lal PathLabs Limited was founded in 1949 and is based in Gurugram, India.
P/E ratio for Dr. Lal PathLabs Limited (LALPATHLAB.NS)
P/E ratio as of 2023: 53.16
According to Dr. Lal PathLabs Limited's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 53.16. At the end of 2022 the company had a P/E ratio of 63.45.
P/E ratio history for Dr. Lal PathLabs Limited from 2010 to 2023
PE ratio at the end of each year
| Year | P/E ratio |
|---|---|
| 2023 | 53.16 |
| 2022 | 63.45 |
| 2021 | 62.61 |
| 2020 | 76.62 |
| 2019 | 51.12 |
| 2018 | 43.40 |
| 2017 | 41.81 |
| 2016 | 51.00 |
| 2015 | 57.38 |
| 2014 | 47.32 |
| 2013 | 85.67 |
| 2012 | 123.67 |
| 2011 | 152.48 |
| 2010 | 234.14 |